Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...

InflaRx (NASDAQ:IFRX) highlighted recent clinical updates and strategic priorities for its complement inhibition platform during a presentation at Oppenheimer’s 36th Annual Healthcare Life Sciences ...

Researchers discover that COVID-19 uniquely causes brain inflammation and disrupts serotonin/dopamine pathways, explaining "brain fog" in Long COVID.

Autoimmune disease is often associated with an increased risk of thrombosis by a variety of mechanisms. As diagnostic techniques have advanced, the role of antibodies that target proteins involved in ...

Hypertension is often described in simple terms: a chronic condition in which blood pressure remains persistently elevated. Yet behind those numbers o.

Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to respond well to standard drug .

Annexon Biosciences ( (ANNX)) has shared an announcement. On February 12, 2026, Annexon, Inc. announced that Chairman of the Board Thomas G. Wiggans will retire from the board and not stand for ...

The interplay between host immunity, the microbiota, and cancer is a rapidly evolving area of immuno-oncology. An increasing body of evidence highlights the ...

Barclays started coverage of Regeneron Pharmaceuticals with an Overweight rating and a $923 price target, saying the company’s shares undervalue near- and medium-term profit growth from Dupixent and ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

A growing body of research now links the trillions of microbes living in the human gut to how well people age, with recent studies identifying specific bacterial signatures that distinguish healthy ...